We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
Following a review of current evidence and available literature, the malaria advice and malaria map for Indonesia have today been updated and a number of changes made.
These changes reflect the consensus opinion of the Scottish Malaria Advisory Group (SMAG).
The main change in recommendations is that for some areas where antimalarial chemoprophylaxis was previously advised for all travellers, antimalarials will now only be considered for a sub-set of travellers who may be at higher risk.
The highest risk areas for malaria in Indonesia continue to be in the five eastern provinces of East Nusa Tengarra, Maluku, North Maluku, Papua and West Papua, where antimalarials are still advised for all travellers.
Prevention of mosquito bites and prompt diagnosis and treatment of fever are essential for all travellers to all areas of Indonesia.
